Citigroup Argues KV Pharma Knew ARS Risks
Citigroup Global Markets Inc. has urged a court to toss a suit brought by KV Pharmaceutical Co. in the wake of the auction rate securities fiasco, saying the drugmaker cannot use...To view the full article, register now.
Already a subscriber? Click here to view full article